Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Management of iTTP

Yazan Abou-Ismail

Evolving Treatment Landscape in ITP

Robert Bird

ITP: Diagnosis, Pathophysiology, and Management Guidelines

Songphol Tungjitviboonkun

Sequencing Treatments in Hemophilia A: When to Switch and Why

Cedric R. Hermans

Causes of Secondary ITP and Long-Term Risk of Other Diseases in ITP …

Platelet Disorder Support Association (PDSA)

D. Kuter